Tozaro appoints Jason Slingsby as CEO to lead commercial strategy in cell and gene therapy sector
Ella Day | May 1, 2025 | Appointment | Manufacturing Services, Manufacturing and Production, Research and Development | CEO, CGT, Jason Slingsby, Michele Pedrocchi, Pharmacy, Tozaro, manufacturing
Tozaro, a technology provider specialising in cell and gene therapy (CGT) manufacturing, has appointed Jason Slingsby (pictured left) as its new chief executive officer (CEO). This supports Tozaro’s intent to accelerate the commercialisation of its Smart Polymer technology, which aims to enhance downstream viral vector manufacturing in CGT.
Slingsby succeeds interim CEO Guy Leaver, who remains on Tozaro’s board. He led the company since its transition to the CGT bioprocessing sector in August 2024.
Slingsby brings over two decades of experience in biotech commercialisation, mergers and acquisitions, and strategic partnerships, including senior leadership roles at LifeArc and Oxford Biomedica. Additionally, he co-founded ProtAffin, a clinical-stage biologics company.
“I look forward to leading the company through this commercialisation phase, allowing our partners to go beyond the limits of what was previously thought possible in biology,” stated Slingsby.
Non-executive director at Tozaro, Elizabeth Klein, added: “Jason is ideally placed to firmly establish Tozaro’s position as a technology pioneer in the CGT manufacturing space.”
The company has also appointed Michele Pedrocchi (pictured right) as non-executive chair. Pedrocchi, who formerly worked at Roche Diagnostics, has extensive board and strategy experience across healthcare and precision medicine sectors. He commented: “I’m delighted to step up to the position of chair and to welcome Jason as CEO.”
Ella Day
1/5/25
Related Content
Tozaro forms Technical Advisory Board to accelerate Smart Polymer commercialisation for CGT bioprocessing
Tozaro, a UK-based biopharma focused on cell and gene therapy (CGT), has announced the formation …
CARBOGEN AMCIS manufacturing license advances services in China
Swiss pharma manufacturing company, CARBOGEN AMCIS, has announced that its facility in Shanghai, China, has …
Meribel Pharma Solutions launches to take pharma services to new heights
Meribel Pharma Solutions, a new mid-sized contract development and manufacturing organisation (CDMO), has officially launched …
